Regulatory developments—such as the Stark Law blanket waivers and the OIG’s enforcement deferral for use of the waivers—have helped healthcare providers during the COVID-19 crisis, but healthcare fraud remains a prime target of the DOJ and the OIG (in addition to state regulators). Between October 2018 and September 2019, the DOJ obtained over $3 billion in judgments and settlements from fraud claims, a substantial portion of those claims relating to healthcare fraud.[1] The significant increase in qui tam litigation since the 1980s is also notable.[2] So what fraud and abuse actions could regulators pursue in COVID-19’s shadow?
Continue Reading Do Covid-19 Regulatory Changes Pose an Increased Risk of Fraud and Abuse Liability for Healthcare Providers?
COVID Recovery – Providing Quality Healthcare and Staying Ahead of the COVID-19 Curve—Complicated!
In this on demand webinar Shareholder Kevin Wood will cover how medical practices’ can stay ahead of the curve in the COVID environment. This presentation is from the MGMA Texas virtual Annual Meeting that took place September 8-11.
Healthy IT Contracts: HIPAA and Beyond
In this on demand webinar Shareholder Corinne Smith will cover the importance of medical practice IT contracts. This presentation is from the MGMA Texas virtual Annual Meeting that took place September 8-11.
Physician Non-Compete Agreements and the Anti-Kickback and Physician Self-Referral Laws
It is common practice for a hospital to require a physician to sign a non-compete agreement whenever the hospital employs the physician or acquires the physician’s medical practice. In certain respects, that is to be expected. Non-compete agreements are a common feature in employment agreements and business acquisition documents across all industries and therefore it